Predicting Success in the Biotech and Pharma Sectors Mark Schoenebaum of ISI Group earned two top spots on this year's All-America Research Team. Here he explains how he differentiates the good stocks from the bad. Related Articles Now Top Investors Are Doubting the AI Revolution Michelle Celarier Geopolitics Trump AI as Top Investor Concern While Tech Remains Long-Term Focus James Comtois Venezuela and Oil Prices Sponsored by Fidelity Investments